Identification of genetic components of drug response
AssigneeVariagenics, Inc.
InventorVincent P. Stanton JR.
Life of this patent
Estimating the term…
Loading patent…
AssigneeVariagenics, Inc.
InventorVincent P. Stanton JR.
Estimating the term…
The present invention is concerned generally with the field of identifying an appropriate treatment regimen for a disease based upon genotype in mammals, particularly in humans. It is further concerned with the genetic basis of inter-patient variation in response to therapy, including drug therapy. Specifically, this invention describes the identification of gene sequence variances useful in the field of therapeutics for optimizing efficacy and safety of drug therapy. These variances may be useful during the drug development process and in guiding the optimal use of already approved compounds. DNA sequence variances in candidate genes (i.e., genes that may plausibly affect the action of a drug) are tested in clinical trials, leading to the establishment of diagnostic tests useful for improving the development of new pharmaceutical products and/or the more effective use of existing pharmaceutical products. Methods for identifying genetic variances and determining their utility in the selection of optimal therapy for specific patients are also described. In general, the invention relates to methods for identifying patient population subsets that respond to drug therapy with either therapeutic benefit or side effects (i.e., symptomatology prompting concern about safety or other unwanted signs or symptoms).
A method for identifying phenotypes that vary in cell lines as a result of genetic variation, comprising:
A method for identifying phenotypes that vary in cell lines as a result of genetic variation, comprising:
A method for identifying mRNAs that vary in levels as a result of genetic variation, comprising:
A method for the identification of phenotypes that vary among cell lines as a consequence of genetic variation, the method comprising:
Dependencies are inferred from the claim text.